Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy

Name: Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy
License: Public Domain

Universitätsklinikum Hamburg-Eppendorf

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

head-and-neck-cancer

head and neck cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174869
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.